Population
Experimental autoimmune encephalomyelitis (EAE) animal model of multiple sclerosis (MS)
Comparison
Anti-CSF-1 neutralizing monoclonal antibody vs CSF-1R inhibitor BLZ945 or IL-34 neutralization
Design
Preclinical
Authors
Loading...
Supports CSF-1 neutralization in EAE; hypothesis-generating for MS translation.
Targeting CSF-1 with neutralizing antibodies halts EAE progression by selectively depleting inflammatory myeloid cells, offering a potential targeted therapy for multiple sclerosis.
Shiu et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: